Literature DB >> 9857955

1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats.

M Gerlach1, A Y Xiao, C Heim, J Lan, R God, D Feineis, G Bringmann, P Riederer, K H Sontag.   

Abstract

1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a neurotoxin structurally similar to the dopaminergic neurotoxin MPTP, may be formed in humans treated with chloral hydrate or exposed to trichloroethylene, a widely used industrial solvent. Systemically administered TaClo (0.4 mg/kg, i.p.) induced an immediate and transient release of dopamine (DA) and serotonin (5-HT) measured using microdialysis. However, only 5-HT was increased significantly (area under the curve, AUC, for the 1-2 h-period following TaClo administration: 400% compared with the respective control value; 2-3 h-period: 326%). This was followed by a progressive increase in hydroxyl radical formation reflected by higher extracellular concentrations of the hydroxylate product of salicylic acid, 2,3-dihydroxybenzoic acid (AUC for the 1-2 h period following TaClo administration: 182% compared with the respective control value; 2-3 h period: 190%). In contrast, extracellular glutamate and GABA were increased 2-3 h post-injection by 64 and 51%, respectively. These data suggest that TaClo stimulates the generation of hydroxyl free radicals via an acute release of 5-HT and perhaps DA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857955     DOI: 10.1016/s0304-3940(98)00791-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Real-time monitoring of superoxide generation and cytotoxicity in neuroblastoma mitochondria induced by 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline.

Authors:  Sarah Jayne Boulton; Paul C Keane; Christopher M Morris; Calum J McNeil; Philip Manning
Journal:  Redox Rep       Date:  2012-05-30       Impact factor: 4.412

2.  Trichloroethylene and Parkinson's Disease: Risk Assessment.

Authors:  Mei Liu; Eun-Joo Shin; Duy-Khanh Dang; Chun-Hui Jin; Phil Ho Lee; Ji Hoon Jeong; Seok-Joo Park; Yong-Sun Kim; Bin Xing; Tao Xin; Guoying Bing; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2017-12-22       Impact factor: 5.590

3.  The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats.

Authors:  M Gerlach; A Y Xiao; W Kuhn; R Lehnfeld; P Waldmeier; K H Sontag; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

Review 4.  Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease?

Authors:  A Barzilai; E Melamed; A Shirvan
Journal:  Cell Mol Neurobiol       Date:  2001-06       Impact factor: 5.046

5.  Effect of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) on human serotonergic cells.

Authors:  G Bringmann; R Brückner; R Mössner; D Feineis; A Heils; K P Lesch
Journal:  Neurochem Res       Date:  2000-06       Impact factor: 3.996

6.  Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells.

Authors:  A Storch; Y-I Hwang; G Bringmann; D Feineis; S Ott; R Brückner; J Schwarz
Journal:  J Neural Transm (Vienna)       Date:  2006-08-01       Impact factor: 3.575

Review 7.  Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.

Authors:  Edward A Lock; Jing Zhang; Harvey Checkoway
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-07       Impact factor: 4.219

8.  Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline.

Authors:  Thomas A Sontag; Klaus W Lange; Christine Heim; Waclav Kolasiewicz; Oliver Tucha; Karl-Heinz Sontag
Journal:  J Neural Transm (Vienna)       Date:  2009-07-16       Impact factor: 3.575

9.  Basic studies on epigenetic carcinogenesis of low-dose exposure to 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in vitro.

Authors:  Renjie Wang; Yi Cui; Yi Xu; Joseph Irudayaraj
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.